skip to content

Cambridge Public Health

 

My interests are: Genomics and blood donor health; Molecular pathology of breast cancer and disease prognosis; Inherited genetics and side effects (toxicity) of chemotherapy for breast cancer; Inherited genetics and clinical outcome (prognosis) in breast cancer

Publications from Elements

Datasets

2019 (No publication date)

  • Castle, C., Angelaki, M., Bhatti, J., Cadwallader, L., Cardona, A., Cronin, G., Dawson, E., Downie, A., Eckes, A., Eglen, S., Finoia, P., Gogleva, A., Guo, Q., Haverkamp, K., Jones, D., Kingsley, D., Lavagnini, E., Madsen, R., Martinez Cuesta, S., Mohammadi, A., O'Reilly, M., Peter, Q., Redhouse, D., Roberts, R., Savage, J., Sovio, U., Sparrow, L., Talbot, A., Thwaites, A. and von Ziegenweidt, J., 2019 (No publication date). Data Champions Stakeholder Analysis
  • Journal articles

    2019 (Accepted for publication)

  • Sun, Y-Q., Burgess, S., Staley, JR., Wood, AM., Bell, S., Kaptoge, SK., Guo, Q., Bolton, T., Mason, AM., Butterworth, AS., Di Angelantonio, E., Vie, GÅ., Bjørngaard, JH., Kinge, JM., Chen, Y. and Mai, X-M., 2019 (Accepted for publication). Body mass index and all-cause mortality in the HUNT and UK Biobank studies: Linear and non-linear Mendelian randomization analyses BMJ,
  • Kaptoge, S., Pennells, L., De Bacquer, D., Bell, S., Chowdhury, R., Sofianopoulou, E., Wareham, N., Wood, A., Danesh, J. and Di Angelantonio, E., 2019 (Accepted for publication). World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions The Lancet Global Health,
  • 2019

  • Ference, BA., Bhatt, DL., Catapano, AL., Packard, CJ., Graham, I., Kaptoge, S., Ference, TB., Guo, Q., Laufs, U., Ruff, CT., Cupido, A., Hovingh, GK., Danesh, J., Holmes, MV., Smith, GD., Ray, KK., Nicholls, SJ. and Sabatine, MS., 2019. Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular Disease. JAMA: Journal of the American Medical Association, v. 322
    Doi: http://doi.org/10.1001/jama.2019.14120
  • 2018 (Accepted for publication)

  • Guo, Q., Escala-Garcia, M. and Pharoah, P., 2018 (Accepted for publication). Genome-wide association study of germline variants and breast cancer-specific mortality British Journal of Cancer,
  • 2017 (Accepted for publication)

  • Guo, Q. and et al, , 2017 (Accepted for publication). Body Mass Index and Breast Cancer Survival: A Mendelian Randomisation Analysis International Journal of Epidemiology, v. 46
    Doi: http://doi.org/10.1093/ije/dyx131
  • 2017

  • Fagerholm, R., Khan, S., Schmidt, MK., García-Closas, M., Heikkilä, P., Saarela, J., Beesley, J., Jamshidi, M., Aittomäki, K., Liu, J., Ali, HR., Andrulis, IL., Beckmann, MW., Behrens, S., Blows, FM., Brenner, H., Chang-Claude, J., Couch, FJ., Czene, K., Fasching, PA., Figueroa, J., Floris, G., Glendon, G., Guo, Q., Hall, P., Hallberg, E., Hamann, U., Holleczek, B., Hooning, MJ., Hopper, JL., Jager, A., Kabisch, M., kConFab/AOCS Investigators, , Keeman, R., Kosma, V-M., Lambrechts, D., Lindblom, A., Mannermaa, A., Margolin, S., Provenzano, E., Shah, M., Southey, MC., Dennis, J., Lush, M., Michailidou, K., Wang, Q., Bolla, MK., Dunning, AM., Easton, DF., Pharoah, PDP., Chenevix-Trench, G., Blomqvist, C. and Nevanlinna, H., 2017. TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer. Oncotarget, v. 8
    Doi: http://doi.org/10.18632/oncotarget.15110
  • Easton, DF., Antoniou, AA. and Pharoah, PDP., 2017. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer Nature Genetics, v. 49
    Doi: http://doi.org/10.1038/ng.3785
  • Jiao, X. and Easton, DF., 2017. PHIP – a novel candidate breast cancer susceptibility locus on 6q14.1 Oncotarget, v. 8
    Doi: http://doi.org/10.18632/oncotarget.21800
  • 2015

  • Pirie, A., Guo, Q., Kraft, P., Canisius, S., Eccles, DM., Rahman, N., Nevanlinna, H., Chen, C., Khan, S., Tyrer, J., Bolla, MK., Wang, Q., Dennis, J., Michailidou, K., Lush, M., Dunning, AM., Shah, M., Czene, K., Darabi, H., Eriksson, M., Lambrechts, D., Weltens, C., Leunen, K., van Ongeval, C., Nordestgaard, BG., Nielsen, SF., Flyger, H., Rudolph, A., Seibold, P., Flesch-Janys, D., Blomqvist, C., Aittomäki, K., Fagerholm, R., Muranen, TA., Olsen, JE., Hallberg, E., Vachon, C., Knight, JA., Glendon, G., Mulligan, AM., Broeks, A., Cornelissen, S., Haiman, CA., Henderson, BE., Schumacher, F., Le Marchand, L., Hopper, JL., Tsimiklis, H., Apicella, C., Southey, MC., Cross, SS., Reed, MWR., Giles, GG., Milne, RL., McLean, C., Winqvist, R., Pylkäs, K., Jukkola-Vuorinen, A., Grip, M., Hooning, MJ., Hollestelle, A., Martens, JWM., van den Ouweland, AMW., Marme, F., Schneeweiss, A., Yang, R., Burwinkel, B., Figueroa, J., Chanock, SJ., Lissowska, J., Sawyer, EJ., Tomlinson, I., Kerin, MJ., Miller, N., Brenner, H., Butterbach, K., Holleczek, B., Kataja, V., Kosma, VM., Hartikainen, JM., Li, J. and Brand, JS., 2015. Common germline polymorphisms associated with breast cancer-specific survival Breast Cancer Research,
    Doi: http://doi.org/10.1186/s13058-015-0570-7
  • Jamshidi, M., Fagerholm, R., Khan, S., Aittomäki, K., Czene, K., Darabi, H., Li, J., Andrulis, IL., Chang-Claude, J., Devilee, P., Fasching, PA., Michailidou, K., Bolla, MK., Dennis, J., Wang, Q., Guo, Q., Rhenius, V., Cornelissen, S., Rudolph, A., Knight, JA., Loehberg, CR., Burwinkel, B., Marme, F., Hopper, JL., Southey, MC., Bojesen, SE., Flyger, H., Brenner, H., Holleczek, B., Margolin, S., Mannermaa, A., Kosma, V-M., kConFab Investigators, , Van Dyck, L., Nevelsteen, I., Couch, FJ., Olson, JE., Giles, GG., McLean, C., Haiman, CA., Henderson, BE., Winqvist, R., Pylkäs, K., Tollenaar, RAEM., García-Closas, M., Figueroa, J., Hooning, MJ., Martens, JWM., Cox, A., Cross, SS., Simard, J., Dunning, AM., Easton, DF., Pharoah, PDP., Hall, P., Blomqvist, C., Schmidt, MK. and Nevanlinna, H., 2015. SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival. Oncotarget, v. 6
    Doi: http://doi.org/10.18632/oncotarget.4991
  • Pirie, A., Guo, Q., Kraft, P., Canisius, S., Eccles, DM., Rahman, N., Nevanlinna, H., Chen, C., Khan, S., Tyrer, J., Bolla, MK., Wang, Q., Dennis, J., Michailidou, K., Lush, M., Dunning, AM., Shah, M., Czene, K., Darabi, H., Eriksson, M., Lambrechts, D., Weltens, C., Leunen, K., van Ongeval, C., Nordestgaard, BG., Nielsen, SF., Flyger, H., Rudolph, A., Seibold, P., Flesch-Janys, D., Blomqvist, C., Aittomäki, K., Fagerholm, R., Muranen, TA., Olsen, JE., Hallberg, E., Vachon, C., Knight, JA., Glendon, G., Mulligan, AM., Broeks, A., Cornelissen, S., Haiman, CA., Henderson, BE., Schumacher, F., Le Marchand, L., Hopper, JL., Tsimiklis, H., Apicella, C., Southey, MC., Cross, SS., Reed, MW., Giles, GG., Milne, RL., McLean, C., Winqvist, R., Pylkäs, K., Jukkola-Vuorinen, A., Grip, M., Hooning, MJ., Hollestelle, A., Martens, JW., van den Ouweland, AM., Marme, F., Schneeweiss, A., Yang, R., Burwinkel, B., Figueroa, J., Chanock, SJ., Lissowska, J., Sawyer, EJ., Tomlinson, I., Kerin, MJ., Miller, N., Brenner, H., Butterbach, K., Holleczek, B., Kataja, V., Kosma, V-M., Hartikainen, JM., Li, J., Brand, JS., Humphreys, K., Devilee, P., Tollenaar, RA., Seynaeve, C., Radice, P., Peterlongo, P., Manoukian, S., Ficarazzi, F., Beckmann, MW., Hein, A., Ekici, AB., Balleine, R., Phillips, K-A., kConFab Investigators, , Benitez, J., Zamora, MP., Perez, JIA., Menéndez, P., Jakubowska, A., Lubinski, J., Gronwald, J., Durda, K., Hamann, U., Kabisch, M., Ulmer, HU., Rüdiger, T., Margolin, S., Kristensen, V., Nord, S., NBCS Investigators, , Evans, DG., Abraham, J., Earl, H., Poole, CJ., Hiller, L., Dunn, JA., Bowden, S., Yang, R., Campa, D., Diver, WR., Gapstur, SM., Gaudet, MM., Hankinson, S., Hoover, RN., Hüsing, A., Kaaks, R., Machiela, MJ., Willett, W., Barrdahl, M., Canzian, F., Chin, S-F., Caldas, C., Hunter, DJ., Lindstrom, S., Garcia-Closas, M., Couch, FJ., Chenevix-Trench, G., Mannermaa, A., Andrulis, IL., Hall, P., Chang-Claude, J., Easton, DF., Bojesen, SE., Cox, A., Fasching, PA., Pharoah, PD. and Schmidt, MK., 2015. Common germline polymorphisms associated with breast cancer-specific survival. Breast Cancer Res, v. 17
    Doi: http://doi.org/10.1186/s13058-015-0570-7
  • Guo, Q., Schmidt, MK., Kraft, P., Canisius, S., Chen, C., Khan, S., Tyrer, J., Bolla, MK., Wang, Q., Dennis, J., Michailidou, K., Lush, M., Kar, S., Beesley, J., Dunning, AM., Shah, M., Czene, K., Darabi, H., Eriksson, M., Lambrechts, D., Weltens, C., Leunen, K., Bojesen, SE., Nordestgaard, BG., Nielsen, SF., Flyger, H., Chang-Claude, J., Rudolph, A., Seibold, P., Flesch-Janys, D., Blomqvist, C., Aittomäki, K., Fagerholm, R., Muranen, TA., Couch, FJ., Olson, JE., Vachon, C., Andrulis, IL., Knight, JA., Glendon, G., Mulligan, AM., Broeks, A., Hogervorst, FB., Haiman, CA., Henderson, BE., Schumacher, F., Le Marchand, L., Hopper, JL., Tsimiklis, H., Apicella, C., Southey, MC., Cox, A., Cross, SS., Reed, MW., Giles, GG., Milne, RL., McLean, C., Winqvist, R., Pylkäs, K., Jukkola-Vuorinen, A., Grip, M., Hooning, MJ., Hollestelle, A., Martens, JW., van den Ouweland, AM., Marme, F., Schneeweiss, A., Yang, R., Burwinkel, B., Figueroa, J., Chanock, SJ., Lissowska, J., Sawyer, EJ., Tomlinson, I., Kerin, MJ., Miller, N., Brenner, H., Dieffenbach, AK., Arndt, V., Holleczek, B., Mannermaa, A., Kataja, V., Kosma, VM., Hartikainen, JM., Li, J., Brand, JS., Humphreys, K., Devilee, P., Tollenaar, RA., Seynaeve, C., Radice, P., Peterlongo, P., Bonanni, B., Mariani, P., Fasching, PA., Beckmann, MW., Hein, A., Ekici, AB., Chenevix-Trench, G., Balleine, R., kConFab Investigators, , Phillips, KA., Benitez, J., Zamora, MP., Arias Perez, JI., Menéndez, P., Jakubowska, A., Lubinski, J., Jaworska-Bieniek, K., Durda, K., Hamann, U., Kabisch, M., Ulmer, HU., Rüdiger, T., Margolin, S., Kristensen, V., Nord, S., Evans, DG., Abraham, JE., Earl, HM., Hiller, L., Dunn, JA., Bowden, S., Berg, C., Campa, D., Diver, WR., Gapstur, SM., Gaudet, MM., Hankinson, SE., Hoover, RN., Hüsing, A., Kaaks, R., Machiela, MJ., Willett, W., Barrdahl, M., Canzian, F., Chin, SF., Caldas, C., Hunter, DJ., Lindstrom, S., García-Closas, M., Hall, P., Easton, DF., Eccles, DM., Rahman, N., Nevanlinna, H. and Pharoah, PD., 2015. Identification of novel genetic markers of breast cancer survival. J Natl Cancer Inst, v. 107
    Doi: http://doi.org/10.1093/jnci/djv081
  • Guo, Q., Abraham, JE., Caldas, C., Earl, HM., Pharoah, PPD. and PGSNPS investigators, , 2015. Replication of Genetic Polymorphisms Reported to Be Associated with Taxane-Related Sensory Neuropathy in Patients with Early Breast Cancer Treated with Paclitaxel--response. Clin Cancer Res, v. 21
    Doi: http://doi.org/10.1158/1078-0432.CCR-15-0944
  • 2014

  • Abraham, JE., Guo, Q., Dorling, L., Tyrer, J., Ingle, S., Hardy, R., Vallier, AL., Hiller, L., Burns, R., Jones, L., Bowden, SJ., Dunn, JA., Poole, CJ., Caldas, C., Pharoah, PP. and Earl, HM., 2014. Replication of genetic polymorphisms reported to be associated with taxane-related sensory neuropathy in patients with early breast cancer treated with Paclitaxel. Clin Cancer Res, v. 20
    Doi: http://doi.org/10.1158/1078-0432.CCR-13-3232
  • Ghoussaini, M., Edwards, SL., Michailidou, K., Nord, S., Cowper-Sal Lari, R., Desai, K., Kar, S., Hillman, KM., Kaufmann, S., Glubb, DM., Beesley, J., Dennis, J., Bolla, MK., Wang, Q., Dicks, E., Guo, Q., Schmidt, MK., Shah, M., Luben, R., Brown, J., Czene, K., Darabi, H., Eriksson, M., Klevebring, D., Bojesen, SE., Nordestgaard, BG., Nielsen, SF., Flyger, H., Lambrechts, D., Thienpont, B., Neven, P., Wildiers, H., Broeks, A., Van't Veer, LJ., Th Rutgers, EJ., Couch, FJ., Olson, JE., Hallberg, E., Vachon, C., Chang-Claude, J., Rudolph, A., Seibold, P., Flesch-Janys, D., Peto, J., Dos-Santos-Silva, I., Gibson, L., Nevanlinna, H., Muranen, TA., Aittomäki, K., Blomqvist, C., Hall, P., Li, J., Liu, J., Humphreys, K., Kang, D., Choi, J-Y., Park, SK., Noh, D-Y., Matsuo, K., Ito, H., Iwata, H., Yatabe, Y., Guénel, P., Truong, T., Menegaux, F., Sanchez, M., Burwinkel, B., Marme, F., Schneeweiss, A., Sohn, C., Wu, AH., Tseng, C-C., Van Den Berg, D., Stram, DO., Benitez, J., Zamora, MP., Perez, JIA., Menéndez, P., Shu, X-O., Lu, W., Gao, Y-T., Cai, Q., Cox, A., Cross, SS., Reed, MWR., Andrulis, IL., Knight, JA., Glendon, G., Tchatchou, S., Sawyer, EJ., Tomlinson, I., Kerin, MJ., Miller, N., Haiman, CA., Henderson, BE., Schumacher, F., Le Marchand, L., Lindblom, A., Margolin, S., Teo, SH., Yip, CH., Lee, DSC., Wong, TY., Hooning, MJ., Martens, JWM., Collée, JM., van Deurzen, CHM., Hopper, JL., Southey, MC., Tsimiklis, H., Kapuscinski, MK., Shen, C-Y., Wu, P-E., Yu, J-C., Chen, S-T., Alnæs, GG., Borresen-Dale, A-L., Giles, GG., Milne, RL., McLean, C., Muir, K., Lophatananon, A., Stewart-Brown, S., Siriwanarangsan, P., Hartman, M., Miao, H., Buhari, SABS., Teo, YY., Fasching, PA., Haeberle, L., Ekici, AB., Beckmann, MW., Brenner, H., Dieffenbach, AK., Arndt, V., Stegmaier, C., Swerdlow, A., Ashworth, A., Orr, N., Schoemaker, MJ., García-Closas, M., Figueroa, J., Chanock, SJ., Lissowska, J., Simard, J., Goldberg, MS., Labrèche, F., Dumont, M., Winqvist, R., Pylkäs, K., Jukkola-Vuorinen, A., Brauch, H., Brüning, T., Koto, Y-D., Radice, P., Peterlongo, P., Bonanni, B., Volorio, S., Dörk, T., Bogdanova, NV., Helbig, S., Mannermaa, A., Kataja, V., Kosma, V-M., Hartikainen, JM., Devilee, P., Tollenaar, RAEM., Seynaeve, C., Van Asperen, CJ., Jakubowska, A., Lubinski, J., Jaworska-Bieniek, K., Durda, K., Slager, S., Toland, AE., Ambrosone, CB., Yannoukakos, D., Sangrajrang, S., Gaborieau, V., Brennan, P., McKay, J., Hamann, U., Torres, D., Zheng, W., Long, J., Anton-Culver, H., Neuhausen, SL., Luccarini, C., Baynes, C., Ahmed, S., Maranian, M., Healey, CS., González-Neira, A., Pita, G., Alonso, MR., Alvarez, N., Herrero, D., Tessier, DC., Vincent, D., Bacot, F., de Santiago, I., Carroll, J., Caldas, C., Brown, MA., Lupien, M., Kristensen, VN., Pharoah, PDP., Chenevix-Trench, G., French, JD., Easton, DF., Dunning, AM., Australian Ovarian Cancer Management Group, and Australian Ovarian Cancer Management Group, , 2014. Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. Nature Communications, v. 5
    Doi: http://doi.org/10.1038/ncomms5999
  • 2013

  • Pharoah, PDP., Tsai, Y-Y., Ramus, SJ., Phelan, CM., Goode, EL., Lawrenson, K., Buckley, M., Fridley, BL., Tyrer, JP., Shen, H., Weber, R., Karevan, R., Larson, MC., Song, H., Tessier, DC., Bacot, F., Vincent, D., Cunningham, JM., Dennis, J., Dicks, E., Australian Cancer Study, , Australian Ovarian Cancer Study Group, , Aben, KK., Anton-Culver, H., Antonenkova, N., Armasu, SM., Baglietto, L., Bandera, EV., Beckmann, MW., Birrer, MJ., Bloom, G., Bogdanova, N., Brenton, JD., Brinton, LA., Brooks-Wilson, A., Brown, R., Butzow, R., Campbell, I., Carney, ME., Carvalho, RS., Chang-Claude, J., Chen, YA., Chen, Z., Chow, W-H., Cicek, MS., Coetzee, G., Cook, LS., Cramer, DW., Cybulski, C., Dansonka-Mieszkowska, A., Despierre, E., Doherty, JA., Dörk, T., du Bois, A., Dürst, M., Eccles, D., Edwards, R., Ekici, AB., Fasching, PA., Fenstermacher, D., Flanagan, J., Gao, Y-T., Garcia-Closas, M., Gentry-Maharaj, A., Giles, G., Gjyshi, A., Gore, M., Gronwald, J., Guo, Q., Halle, MK., Harter, P., Hein, A., Heitz, F., Hillemanns, P., Hoatlin, M., Høgdall, E., Høgdall, CK., Hosono, S., Jakubowska, A., Jensen, A., Kalli, KR., Karlan, BY., Kelemen, LE., Kiemeney, LA., Kjaer, SK., Konecny, GE., Krakstad, C., Kupryjanczyk, J., Lambrechts, D., Lambrechts, S., Le, ND., Lee, N., Lee, J., Leminen, A., Lim, BK., Lissowska, J., Lubiński, J., Lundvall, L., Lurie, G., Massuger, LFAG., Matsuo, K., McGuire, V., McLaughlin, JR., Menon, U., Modugno, F., Moysich, KB., Nakanishi, T., Narod, SA., Ness, RB., Nevanlinna, H., Nickels, S., Noushmehr, H., Odunsi, K., Olson, S., Orlow, I., Paul, J., Pejovic, T., Pelttari, LM., Permuth-Wey, J., Pike, MC., Poole, EM., Qu, X., Risch, HA., Rodriguez-Rodriguez, L., Rossing, MA., Rudolph, A., Runnebaum, I., Rzepecka, IK., Salvesen, HB., Schwaab, I., Severi, G., Shen, H., Shridhar, V., Shu, X-O., Sieh, W., Southey, MC., Spellman, P., Tajima, K., Teo, S-H., Terry, KL., Thompson, PJ., Timorek, A., Tworoger, SS., van Altena, AM., van den Berg, D., Vergote, I., Vierkant, RA., Vitonis, AF., Wang-Gohrke, S., Wentzensen, N., Whittemore, AS., Wik, E., Winterhoff, B., Woo, YL., Wu, AH., Yang, HP., Zheng, W., Ziogas, A., Zulkifli, F., Goodman, MT., Hall, P., Easton, DF., Pearce, CL., Berchuck, A., Chenevix-Trench, G., Iversen, E., Monteiro, ANA., Gayther, SA., Schildkraut, JM. and Sellers, TA., 2013. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet, v. 45
    Doi: http://doi.org/10.1038/ng.2564
  • Tyrer, JP., Guo, Q., Easton, DF. and Pharoah, PDP., 2013. The admixture maximum likelihood test to test for association between rare variants and disease phenotypes. BMC Bioinformatics, v. 14
    Doi: http://doi.org/10.1186/1471-2105-14-177
  • Pashayan, N., Guo, Q. and Pharoah, PD., 2013. Personalized screening for cancers: Should we consider polygenic profiling? Personalized Medicine, v. 10
    Doi: http://doi.org/10.2217/pme.13.46
  • 2010

  • Guo, Q., Guo, F. and Shao, J., 2010. Irregular shape symmetry analysis: theory and application to quantitative galaxy classification. IEEE Trans Pattern Anal Mach Intell, v. 32
    Doi: http://doi.org/10.1109/TPAMI.2010.13
  • Conference proceedings

    2018

  • Garcia, ME., Guo, Q., Wessels, L., Bader, G., Pharoah, P., Chenevix-Trench, G., Easton, D., Canisius, S. and Schmidt, M., 2018. Pathway analysis suggests biological processes driven by germline genetic associations with breast cancer prognosis CANCER RESEARCH, v. 78
    Doi: http://doi.org/10.1158/1538-7445.AM2018-2271
  • 2017

  • Ramond, A., Surendran, P., Jiang, T., Guo, Q., Howson, JMM., Butterworth, A. and Di Angelantonio, E., 2017. Insights into Iron Metabolism: Discovery of New Genetic Loci Associated with Soluble Tansferrin Receptor GENETIC EPIDEMIOLOGY, v. 41
  • Schmidt, MK., Guo, Q., Dork, T., Eccles, D., Keeman, R., Simard, J., Kraft, P., Easton, DF. and Pharoah, PD., 2017. Genome-wide association studies of breast cancer prognosis CANCER RESEARCH, v. 77
    Doi: http://doi.org/10.1158/1538-7445.AM2017-2258
  • 2015 (No publication date)

  • Earl, HM., ABRAHAM, JE., GUO, Q., PHAROAH, P. and CALDAS, C., 2015 (No publication date). Detection of pharmacokinetic candidate genes associated with taxane related neurotoxicity by genome-wide association studies. poster,
  • Earl, HM., ABRAHAM, J., RUEDA, OM., SUET-FEUNG, C., QI, G., HARRINGTON, P., PHAROAH, P. and CALDAS, C., 2015 (No publication date). Copy number variation and risk of chemotherapy-related infection. Cancer Research 2012, v. 72(24)